previous | next

Graphics

Figure GPS-1: Proportion of all adults (15 to 64 years old) using cannabis daily or almost daily among current users (used in the last 30 days)

Figure GPS-2: Recent use (last year) of cannabis among young adults, 15 to 34 and 15 to 24 years old age group, measured by population surveys

Figure GPS-3: Current use (last month) of cannabis among young adults (aged 15 to 24), measured by national surveys

Figure GPS-4: Trends in recent use (last year) of cannabis among young adults (aged 15-34), measured by national surveys

Figure GPS-5:Recent use (last year) of amphetamines among young adults, 15 to 34 and 15 to 24, measured by population surveys

Figure GPS-6:Trends in recent use (last year) of amphetamines among young adults (aged 15 to 34), measured by population surveys

Figure GPS-7:Lifetime prevalence and recent (last year) use of ecstasy among young adults at selected ages, 15 to 34 and 15 to 24, measured by population surveys

Figure GPS-8:Trends in recent use (last year) of ecstasy among young adults (aged 15 to 34), measured by population surveys

Figure GPS-9:Recent use (last year) of cocaine among all young adults and young males, measured by national surveys

Figure GPS-10:Trends in recent use (last year) of cocaine among young adults (aged 15 to 34), measured by population surveys

Figure GPS-11:Lifetime prevalence of cannabis among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-12:Last year prevalence of cannabis among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-13:Current use (last 30 days) prevalence of cannabis among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-14:Trends in recent use (last year) of cannabis among young adults (aged 15 to 24), measured by national surveys

Figure GPS-15:Lifetime prevalence of amphetamine use among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-16:Last year prevalence of amphetamines among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-17:Trends in recent use (last year) of amphetamines among young adults (aged 15 to 24) by national surveys

Figure GPS-18:Lifetime prevalence of ecstasy among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-19:Last year prevalence of ecstasy among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-20:Trends in recent use (12 month) of ecstasy among young adults (aged 15 to 24)

Figure GPS-21: Lifetime prevalence of cocaine use among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group, in some EU countries

Figure GPS-22: Last year prevalence of cocaine use among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Figure GPS-23 part (i): Recent use (last year) of amphetamines, ecstasy and cocaine among young adults (aged 15 to 34)

Figure GPS-23 part (ii): Recent use (last 12 month) of amphetamines, ecstasy and cocaine among young adults (aged 15 to 24)

Figure GPS-24 part (i): Continuation rate of cannabis (last year prevalence as a proportion of lifetime prevalence)

Figure GPS-24 part (ii): Continuation rate of cocaine (last year prevalence as a proportion of lifetime prevalence)

Figure GPS-24 part (iii): Continuation rate of ecstasy (last year prevalence as a proportion of lifetime prevalence)